# Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions

> **NCT00759902** · PHASE1 · COMPLETED · sponsor: **Actavis Inc.** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** morphine sulfate extended-release capsules
- **DRUG:** KADIAN (morphine sulfate extended-release) capsules

## Key facts

- **NCT ID:** NCT00759902
- **Lead sponsor:** Actavis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2006-09
- **Final completion:** 2006-10
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2010-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00759902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00759902, "Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00759902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*